If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist (LAMA) or a Leukotriene Receptor Antagonist (LTRA) on top of a moderate-dose ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

Please provide your email address to receive an email when new articles are posted on . The NIH has released new recommendations for the diagnosis, management and treatment of asthma in adolescents ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

A peak flow meter is a simple, small, hand-held tool that can help you maintain control of asthma by providing a measurement of how well air moves out of the lungs. After blowing into the device, the ...

As evidenced by a debate at the CHEST Annual Meeting 2023, the pulmonology community disagrees on whether the overlap of asthma and chronic obstructive pulmonary disease (COPD) is a distinct entity ...

Please provide your email address to receive an email when new articles are posted on . Even low-dose treatment courses of inhaled corticosteroids for asthma can lead to adrenal suppression including ...

asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...

Asthma is a respiratory condition caused by inflammation and constriction (narrowing) of the airways. It can cause symptoms such as shortness of breath, coughing, or wheezing. Asthma is a long-term ...